Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
丹龙片治疗乳腺增生病(气滞血瘀证)多中心 随机 双盲 安慰剂对照Ⅲ期临床试验
[Translation] A multicenter, randomized, double-blind, placebo-controlled phase III clinical trial of Danlong Tablets in the treatment of breast hyperplasia (Qi stagnation and blood stasis syndrome)
进一步评价丹龙片治疗乳腺增生病(气滞血瘀证)的临床有效性及安全性
[Translation] To further evaluate the clinical efficacy and safety of Danlong Tablets in the treatment of breast hyperplasia (Qi stagnation and blood stasis syndrome)
100 Clinical Results associated with Sichuan Enwei Traditional Chinese Medicine Research and Development Co., Ltd.
0 Patents (Medical) associated with Sichuan Enwei Traditional Chinese Medicine Research and Development Co., Ltd.
100 Deals associated with Sichuan Enwei Traditional Chinese Medicine Research and Development Co., Ltd.
100 Translational Medicine associated with Sichuan Enwei Traditional Chinese Medicine Research and Development Co., Ltd.